BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15388990)

  • 1. Inducible mouse models for inherited skin diseases: implications for skin gene therapy.
    Arin MJ; Roop DR
    Cells Tissues Organs; 2004; 177(3):160-8. PubMed ID: 15388990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Keratin diseases].
    Jensen PK; Sørensen CB; Andresen BS; Brandrup F; Veien NK; Buus SK; Gregersen N; Bolund L
    Ugeskr Laeger; 2000 Mar; 162(13):1867-72. PubMed ID: 10765692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders.
    Arin MJ; Longley MA; Wang XJ; Roop DR
    J Cell Biol; 2001 Feb; 152(3):645-9. PubMed ID: 11157989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the genes for epidermal keratins in epidermolysis bullosa and epidermolytic hyperkeratosis.
    Leigh IM; Lane EB
    Arch Dermatol; 1993 Dec; 129(12):1571-7. PubMed ID: 7504434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis.
    Bickenbach JR; Longley MA; Bundman DS; Dominey AM; Bowden PE; Rothnagel JA; Roop DR
    Differentiation; 1996 Dec; 61(2):129-39. PubMed ID: 8983179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis.
    Müller FB; Huber M; Kinaciyan T; Hausser I; Schaffrath C; Krieg T; Hohl D; Korge BP; Arin MJ
    Hum Mol Genet; 2006 Apr; 15(7):1133-41. PubMed ID: 16505000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy.
    Cao T; Longley MA; Wang XJ; Roop DR
    J Cell Biol; 2001 Feb; 152(3):651-6. PubMed ID: 11157990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermolysis bullosa simplex.
    Coulombe PA; Fuchs E
    Semin Dermatol; 1993 Sep; 12(3):173-90. PubMed ID: 7692916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular genetics of keratin disorders.
    Smith F
    Am J Clin Dermatol; 2003; 4(5):347-64. PubMed ID: 12688839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratin transgenic and knockout mice: functional analysis and validation of disease-causing mutations.
    Vijayaraj P; Söhl G; Magin TM
    Methods Mol Biol; 2007; 360():203-51. PubMed ID: 17172732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel keratin 14 gene mutations in patients from Hungary with epidermolysis bullosa simplex.
    Csikós M; Szalai Z; Becker K; Sebõk B; Schneider I; Horváth A; Kárpáti S
    Exp Dermatol; 2004 Mar; 13(3):185-91. PubMed ID: 14987259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidermic genodermatoses: models of current approch in dermatology].
    Hohl D
    Rev Med Suisse Romande; 1994 Mar; 114(3):277-80. PubMed ID: 8171239
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons from keratin transgenic and knockout mice.
    Magin TM
    Subcell Biochem; 1998; 31():141-72. PubMed ID: 9932492
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidermolysis bullosa simplex: genotype-phenotype correlation in Danish patients].
    Sørensen CB; Ladekjaer-Mikkelsen AS; Andresen BS; Brandrup F; Veien NK; Buus SK; Anton-Lamprecht I; Kruse T; Jensen PK; Eiberg H; Bolund L; Gregersen N
    Ugeskr Laeger; 2000 Mar; 162(13):1873-6. PubMed ID: 10765693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseases.
    D'Alessandro M; Morley SM; Ogden PH; Liovic M; Porter RM; Lane EB
    Gene Ther; 2004 Aug; 11(16):1290-5. PubMed ID: 15215887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of somatic and germline mosaicism for a keratin 5 mutation in epidermolysis bullosa simplex in a family of which the proband was previously regarded as a sporadic case.
    Nagao-Watanabe M; Fukao T; Matsui E; Kaneko H; Inoue R; Kawamoto N; Kasahara K; Nagai M; Ichiki Y; Kitajima Y; Kondo N
    Clin Genet; 2004 Sep; 66(3):236-8. PubMed ID: 15324323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a de novo keratin 1 mutation in epidermolytic hyperkeratosis with palmoplantar involvement.
    Math A; Frank J; Handisurya A; Poblete-Gutiérrez P; Slupetzky K; Födinger D; Winter D; Stingl G; Kirnbauer R
    Eur J Dermatol; 2006; 16(5):507-10. PubMed ID: 17101470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic approaches to understanding the keratinopathies.
    Bale SJ; DiGiovanna JJ
    Adv Dermatol; 1997; 12():99-113; discussion 114. PubMed ID: 8973737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recessive epidermolysis bullosa simplex phenotype reproduced in vitro: ablation of keratin 14 is partially compensated by keratin 17.
    El Ghalbzouri A; Jonkman M; Kempenaar J; Ponec M
    Am J Pathol; 2003 Nov; 163(5):1771-9. PubMed ID: 14578178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of laser capture microscopy in the analysis of mouse models of human diseases.
    Arin MJ; Roop DR
    Methods Enzymol; 2002; 356():207-15. PubMed ID: 12418199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.